Blood plasma derivatives are derived from donated human blood plasma that are processed and purified to manufacture therapeutics and medicines. Some key plasma derivatives include immunoglobulins, albumin, coagulation factor concentrates, protease inhibitors and other specialized medicines. These plasma derivatives have wide application in treatment of immunodeficiency disorders, haemophilia, hemorrhage and other chronic diseases. The growing prevalence of neurological, immunological and bleeding disorders globally has substantially increased the demand for plasma derived medicines in recent years.
The global Blood Plasma Derivatives Market is estimated to be valued at US$ 44.33 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing demand for plasma derived medicines is a major driver of growth in the blood plasma derivatives market. According to estimates, the global immunoglobulin market size alone is projected to reach US$ 18 billion by 2025, growing at a CAGR of 9% during the forecast period. The increasing adoption of immunoglobulins in treatment of various autoimmune and inflammatory diseases is expected to boost the growth of plasma derivatives market significantly over the coming years. Furthermore, increasing investments by industry players for expanding production facilities and growing access to plasma collection centers especially in developing regions is also anticipated to cater to the accelerating demand for cost-effective plasma medicines globally.
Segment Analysis
The Global Blood Plasma Derivatives Market Size is dominated by the immunoglobulin segment. Immunoglobulin has wide applications in treating various immunodeficiency disorders such as Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and others. The increasing prevalence of primary immunodeficiencies worldwide is driving the demand for immunoglobulin in therapeutic applications.
Key Takeaways
The global blood plasma derivatives market is expected to witness high growth during the forecast period of 2023-2030. The market size is projected to reach US$ 44.33 Bn by 2023, registering a CAGR of 13.%.
Regional analysis
North America dominated the global market in 2022 and is expected to continue its dominance during the forecast period. The rising cases of immune disorders and trauma injuries in the region are driving the demand for blood plasma derivatives. The presence of major players and increasing healthcare expenditure also supports market growth in North America.
Key players
Key players operating in the blood plasma derivatives market are Thermo Fisher Scientific, Inc., Custom Biogenic Systems, Chart Biomedical Co. Ltd., Merck KGaA, Barber-Nichols Inc., Praxair Technology, Inc., Linde LLC, Planer PLC, Cryologic Pty. Ltd., Charter Medicals, Nikkiso Cryo Inc., Cryogenic Control, and Haimen United Laboratory Equipment Development Co., Ltd.
Get More Insights On This Topic: https://www.newsstatix.com/blood-plasma-derivatives-market-size-share-analysis-2023-2030/
